67 related articles for article (PubMed ID: 7029111)
1. [Insulinemia in patients with hyperlipoproteinemia type IIa and V].
Młyński J
Kardiol Pol; 1981; 24(9):605-9. PubMed ID: 7029111
[No Abstract] [Full Text] [Related]
2. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. III. Selected blood serum indicators of carbohydrate metabolism].
Klimek K; Gregorczyk J; Pieczul-Mróz J
Przegl Lek; 1983; 40(10):719-25. PubMed ID: 6364255
[No Abstract] [Full Text] [Related]
3. [Insulinemia after oral and intravenous glucose administration in chronic pancreatitis].
Chciuk-Górnicka M; Szadkowski M; Muszyński J
Pol Tyg Lek; 1980 Sep; 35(36):1369-71. PubMed ID: 7001408
[No Abstract] [Full Text] [Related]
4. [Dynamics of insulinemia in chronic glomerulonephritis].
Kozhevnikov AD; Bobrov IuF
Ter Arkh; 1978; 50(6):68-72. PubMed ID: 675540
[No Abstract] [Full Text] [Related]
5. [Study of phospholipids in primary hyperlipoproteinemias].
Kuczyńska K
Pol Arch Med Wewn; 1979 Jul; 62(1):29-40. PubMed ID: 503884
[No Abstract] [Full Text] [Related]
6. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. VIII. Blood insulin and its direct relation to selected parameters of carbohydrate metabolism].
Klimek K; Gregorczyk J; Olejak B; Pieczul-Mróz D; Morawiec-Borowiak D
Przegl Lek; 1984; 41(3):265-72. PubMed ID: 6377395
[No Abstract] [Full Text] [Related]
7. [Basal insulinemia, its relation to dyslipoproteinemias and arterial pressure].
Suntsov IuI; Mazovetskiĭ AG; Zhukovskiĭ GS; Polesskiĭ VA; Zadoia AA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):33-7. PubMed ID: 7046764
[TBL] [Abstract][Full Text] [Related]
8. [Insulinemia in hypertriglyceridemia caused by long-term carbohydrate-rich diet].
Młyński J
Kardiol Pol; 1981; 24(9):611-7. PubMed ID: 7029112
[No Abstract] [Full Text] [Related]
9. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Artery; 1980; 8(2):113-9. PubMed ID: 7458676
[TBL] [Abstract][Full Text] [Related]
10. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. V. Evaluation of circulatory hemodynamics based on the measurements of systolic time intervals and the physical analysis of blood circulation].
Olejak B; Szmatłoch E; Brzeźniak R; Gregorczyk J; Pieczul-Mróz J; Jankowska E; Jagła A
Przegl Lek; 1983; 40(11):797-801. PubMed ID: 6669732
[No Abstract] [Full Text] [Related]
11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
12. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia.
Brook JG; Aviram M; Luboshitzky R; Barzilai D
Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188
[TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoprotein phenotypes as risk factors in ischemic cardiopathy. II. Clinical aspects].
Walter-Rosianu A
Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(2):145-60. PubMed ID: 6429817
[No Abstract] [Full Text] [Related]
14. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
Jovanović D; Djukanović Lj; Veljović R; Manojlović D
Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
[TBL] [Abstract][Full Text] [Related]
15. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
[No Abstract] [Full Text] [Related]
16. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
17. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. VI. Evaluation of arterial elasticity based on the physical analysis of blood circulation].
Szmatłoch E; Olejak B; Gregorczyk J; Pieczul-Mróz J; Jagła A; Kutrzeba J; Cwajda H
Przegl Lek; 1983; 40(11):803-6. PubMed ID: 6669733
[No Abstract] [Full Text] [Related]
18. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators].
Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H
Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208
[No Abstract] [Full Text] [Related]
19. [Relations between the blood insulin response and kalemia during the glucose tolerance test].
Strollo G; Morè M; Di Cesare T; Di Pietro S; Meloncelli I
Boll Soc Ital Biol Sper; 1981 Nov; 57(21):2137-43. PubMed ID: 7039639
[No Abstract] [Full Text] [Related]
20. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
